Quarterly report pursuant to Section 13 or 15(d)

Accounts Receivables, Contract Assets, and Contract Liabilities - Additional information - (Detail)

v3.22.2.2
Accounts Receivables, Contract Assets, and Contract Liabilities - Additional information - (Detail) - USD ($)
3 Months Ended 9 Months Ended
Oct. 31, 2022
Oct. 31, 2022
Jan. 31, 2022
Receivables [Abstract]      
Deferred revenue, recognized $ 700,000 $ 3,100,000  
Transaction price allocated to performance obligations 27,500,000 27,500,000  
Allowance for unbilled receivables, net 200,000 200,000 $ 0
Impairment losses 0 0  
Revenue recognized related to remaining performance obligations $ 4,200,000 $ 14,200,000